Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 631-638

  Yang, Fan ^a   Liu, Shuo ^a   Wang, Shur Jen ^a   Yu, Chuanhui ^a   Paganini Hill, Annlia ^a   Fisher, Mark J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelium; Fibrinolysis; Microvasculature; Stroke; Tissue plasminogen activator

Indexed keywords

ALBUMIN; CLAUDIN 5; DEXTRAN; FORSKOLIN; GLUCOSE TRANSPORTER 1; MESSENGER RNA; OCCLUDIN; ROLIPRAM; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 83755183462     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335785     Document Type: Article

References (41)

1. Oliver JJ, Webb DJ, Newby DE: Stimulated tissue plasminogen activator release as a marker of endothelial function in humans. Arterioscler Thromb Vasc Biol 2005;25:2470-2479. (Pubitemid 43732266)
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
3. Tran ND, Schreiber SS, Fisher M: Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model. J Cereb Blood Flow Metab 1998;18:1316-1324. (Pubitemid 28559679)
4. Kim JA, Wang SJ, Fisher MJ: Astrocyte regulation of human brain capillary endothelial fibrinolysis. Thromb Res 2003;112:159-165.
5. Tran ND, Correale J, Schreiber SS, Fisher M: Transforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors. Stroke 1999;30:1671-1678. (Pubitemid 29379622)
6. Rosenberg RD, Aird WC: Vascular-bedspecific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555-1564.
7. Baumer Y, Spindler V, Werthmann RC, Bunemann M, Waschke J: Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 2009;220:716-726.
8. Bruckener KE, el Baya A, Galla HJ, Schmidt MA: Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J Cell Sci 2003;116:1837-1846. (Pubitemid 36582170)
9. Di Lorenzo A, Fernandez-Hernando C, Cirino G, Sessa WC: Akt1 is critical for acute inflammation and histaminemediated vascular leakage. Proc Natl Acad Sci U S A 2009;106:14552-14557.
10. Tripathi AK, Sullivan DJ, Stins MF: Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis 2007;195:942-950. (Pubitemid 46452098)
11. Grab DJ, Garcia-Garcia JC, Nikolskaia OV, Kim YV, Brown A, Pardo CA, Zhang Y, Becker KG, Wilson BA, de A Lima AP, Scharfstein J, Dumler JS: Protease activated receptor signaling is required for african trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl Trop Dis 2009;3:e479.
12. Grab DJ, Nyarko E, Nikolskaia OV, Kim YV, Dumler JS: Human brain microvascular endothelial cell traversal by borrelia burgdorferi requires calcium signaling. Clin Microbiol Infect 2009;15:422-426.
13. Adam AP, Sharenko AL, Pumiglia K, Vincent PA: Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem 2010;285:7045-7055.
14. Birukova AA, Burdette D, Moldobaeva N, Xing J, Fu P, Birukov KG: Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP. Microvasc Res 2010;79:128-138.
15. Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR: Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J 2010;24:1023-1034.
16. Sidhaye VK, Chau E, Breysse PN, King LS: Septin-2 mediates airway epithelial barrier function in physiologic and pathologic conditions. Am J Respir Cell Mol Biol 2010;45:120-126.
17. Umapathy NS, Zemskov EA, Gonzales J, Gorshkov BA, Sridhar S, Chakraborty T, Lucas R, Verin AD: Extracellular betanicotinamide adenine dinucleotide (beta-NAD) promotes the endothelial cell barrier integrity via PKA-and EPAC1/ RAC1-dependent actin cytoskeleton rearrangement. J Cell Physiol 2010;223:215-223.
18. Wang Z, Ginnan R, Abdullaev IF, Trebak M, Vincent PA, Singer HA: Calcium/ calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. J Biol Chem 2010;285:21303-21312.
19. Zhao Y, Gorshkova IA, Berdyshev E, He D, Fu P, Ma W, Su Y, Usatyuk PV, Pendyala S, Oskouian B, Saba JD, Garcia JG, Natarajan V: Protection of LPSinduced murine acute lung injury by sphingosine-1-phosphate lyase suppression Am J Respir Cell Mol Biol 2011;45:426-435
20. Eddy EP, Maleef BE, Hart TK, Smith PL: In vitro models to predict bloodbrain barrier permeability. Adv Drug Deliv Rev 1997;23:185-198. (Pubitemid 27047002)
21. Deli MA, Abraham CS, Kataoka Y, Niwa M: Permeability studies on in vitro blood-brain barrier models: Physiology, pathology, and pharmacology. Cell Mol Neurobiol 2005;25:59-127. (Pubitemid 40558585)
22. Tran ND, Wong VL, Schreiber SS, Bready JV, Fisher M: Regulation of brain capillary endothelial thrombomodulin mRNA expression. Stroke 1996;27:2304-2310
23. Shatos MA, Orfeo T, Doherty JM, Penar PL, Collen D, Mann KG: Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cells. Arterioscler Thromb Vasc Biol 1995;15:903-911.
24. Grau GE, de Moerloose P, Bulla O, Lou J, Lei Z, Reber G, Mili N, Ricou B, Morel DR, Suter PM: Haemostatic properties of human pulmonary and cerebral microvascular endothelial cells. Thromb Haemost 1997;77:585-590. (Pubitemid 27121028)
25. Levin EG, Santell L, Osborn KG: The expression of endothelial tissue plasminogen activator in vivo: A function defined by vessel size and anatomic location. J Cell Sci 1997;110:139-148. (Pubitemid 27075858)
26. Levin EG, del Zoppo GJ: Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 1994;144:855-861. (Pubitemid 24160625)
27. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L: Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997;78:386-391. (Pubitemid 27289272)
28. Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Liaw CW, Manning K, Morales J, et al.: A cell culture model of the blood-brain barrier. J Cell Biol 1991;115:1725-1735. (Pubitemid 21910012)
29. Wolburg H, Neuhaus J, Kniesel U, Krauss B, Schmid EM, Ocalan M, Farrell C, Risau W: Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci 1994;107:1347-1357.
30. Liu F, Verin AD, Borbiev T, Garcia JG: Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement. Am J Physiol Lung Cell Mol Physiol 2001;280:L1309-1317.
31. Kooistra MR, Corada M, Dejana E, Bos JL: Epac1 regulates integrity of endothelial cell junctions through VEcadherin. FEBS Lett 2005;579:4966-4972. (Pubitemid 41242837)
32. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN: Regulation of vascular endothelial barrier function by Epac, a cAMPactivated exchange factor for Rap GTPase. Blood 2005;105:1950-1955. (Pubitemid 40731777)
33. Gaillard PJ, de Boer AG: Relationship between permeability status of the bloodbrain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci 2000;12:95-102.
34. Wolburg H, Lippoldt A: Tight junctions of the blood-brain barrier: Development, composition and regulation. Vascul Pharmacol 2002;38:323-337. (Pubitemid 36398254)
35. Feldman GJ, Mullin JM, Ryan MP: Occludin: Structure, function and regulation. Adv Drug Deliv Rev 2005;57:883-917. (Pubitemid 40488109)
36. Abbott NJ, Ronnback L, Hansson E: Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53. (Pubitemid 41828930)
37. Perriere N, Yousif S, Cazaubon S, Chaverot N, Bourasset F, Cisternino S, Decleves X, Hori S, Terasaki T, Deli M, Scherrmann JM, Temsamani J, Roux F, Couraud PO: A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters. Brain Res 2007;1150:1-13. (Pubitemid 46711185)
38. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA: Amyloid-betainduced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2009;14:1101-1112.
39. Plateel M, Teissier E, Cecchelli R: Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain. J Neurochem 1997;68:874-877. (Pubitemid 27044754)
40. Hegeman RJ, van den Eijnden-Schrauwen Y, Emeis JJ: Adenosine 3':5'-cyclic monophosphate induces regulated secretion of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. Thromb Haemost 1998;79:853-858. (Pubitemid 28163867)
41. Susarla R, Watkinson JC, Eggo MC: Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function. J Cell Physiol 2007;212:643-654. (Pubitemid 47267534)